Intra Cellular Therapies | Capital Social E Reservas



Equity Capital And Reserves Alterar Data
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
ALKERMES USD 1.46B 172.88M 2024-12
Biogen USD 16.72B 357.1M 2024-12
Bristol-Myers Squibb USD 16.34B 807M 2024-12
Cytokinetics USD -135372000 121.46M 2024-12
Gilead Sciences USD 19.33B 856M 2024-12
Halozyme Therapeutics USD 363.82M 88.88M 2024-12
Intra Cellular Therapies USD 1.15B 3.63M 2024-12
J&J USD 71.49B 1.33B 2024-12
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Novartis USD 44.05B 729M 2024-12
Prothena USD 486.93M 47.44M 2024-12
RedHill Biopharma USD 61K 2.01M 2024-06
Supernus Pharmaceuticals USD 1.04B 28.58M 2024-12
United Therapeutics USD 6.44B 343.1M 2024-12



Intra Cellular Therapies Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.